Grow Therapy Hits $3B Valuation, Crosses $1B Revenue Mark
Mental health startup Grow Therapy raised $150M in Series D funding, tripling down on insurance-covered therapy.
Grow Therapy just closed a $150 million Series D round, pushing its valuation to $3 billion. The Sequoia Capital-backed startup has also crossed a major milestone: more than $1 billion in annual revenue.
The company's model is straightforward. It connects patients with therapists who accept their insurance — solving one of the most frustrating bottlenecks in mental health care. Finding a therapist is hard enough. Finding one your insurance actually covers? That's been a nightmare for millions of people.
Grow Therapy has clearly found product-market fit at scale. Crossing the billion-dollar revenue threshold puts it in rare company among health tech startups. The fresh capital should fuel further expansion as demand for accessible mental health services continues to surge.
Sequoia's continued backing signals strong confidence in the company's trajectory.